ICON Public Limited Company

NasdaqGS:ICLR Voorraadrapport

Marktkapitalisatie: US$17.7b

ICON Beheer

Beheer criteriumcontroles 4/4

De CEO ICON is Steve Cutler, benoemd in Mar2017, heeft een ambtstermijn van 7.67 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 7.24M, bestaande uit 16.4% salaris en 83.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.045% van de aandelen van het bedrijf, ter waarde $ 7.95M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 8.3 jaar en 7.6 jaar.

Belangrijke informatie

Steve Cutler

Algemeen directeur

US$7.2m

Totale compensatie

Percentage CEO-salaris16.4%
Dienstverband CEO7.7yrs
Eigendom CEO0.04%
Management gemiddelde ambtstermijn8.3yrs
Gemiddelde ambtstermijn bestuur7.6yrs

Recente managementupdates

Recent updates

With A 25% Price Drop For ICON Public Limited Company (NASDAQ:ICLR) You'll Still Get What You Pay For

Nov 02
With A 25% Price Drop For ICON Public Limited Company (NASDAQ:ICLR) You'll Still Get What You Pay For

Here's Why ICON (NASDAQ:ICLR) Has Caught The Eye Of Investors

Sep 25
Here's Why ICON (NASDAQ:ICLR) Has Caught The Eye Of Investors

Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?

Sep 09
Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?

We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt

Aug 25
We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt

An Intrinsic Calculation For ICON Public Limited Company (NASDAQ:ICLR) Suggests It's 28% Undervalued

Aug 10
An Intrinsic Calculation For ICON Public Limited Company (NASDAQ:ICLR) Suggests It's 28% Undervalued

ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)

Jul 13

Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)

Jun 14
Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)

Here's Why We Think ICON (NASDAQ:ICLR) Is Well Worth Watching

May 30
Here's Why We Think ICON (NASDAQ:ICLR) Is Well Worth Watching

ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet

May 14
ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet

ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next

Apr 28
ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next

What Does ICON Public Limited Company's (NASDAQ:ICLR) Share Price Indicate?

Apr 21
What Does ICON Public Limited Company's (NASDAQ:ICLR) Share Price Indicate?

ICON Public Limited Company's (NASDAQ:ICLR) Intrinsic Value Is Potentially 33% Above Its Share Price

Apr 05
ICON Public Limited Company's (NASDAQ:ICLR) Intrinsic Value Is Potentially 33% Above Its Share Price

ICON Public Limited Company (NASDAQ:ICLR) Looks Just Right With A 27% Price Jump

Mar 05
ICON Public Limited Company (NASDAQ:ICLR) Looks Just Right With A 27% Price Jump

With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case

Feb 07
With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case

ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?

Feb 01

These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well

Jan 23
These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well

Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?

Jan 08
Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?

What You Can Learn From ICON Public Limited Company's (NASDAQ:ICLR) P/E

Dec 24
What You Can Learn From ICON Public Limited Company's (NASDAQ:ICLR) P/E

A Look At The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

Dec 09
A Look At The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case

Nov 08
With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case

Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching

Oct 09
Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching

Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Sep 23
Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

Sep 05
Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

Does ICON (NASDAQ:ICLR) Deserve A Spot On Your Watchlist?

Aug 03
Does ICON (NASDAQ:ICLR) Deserve A Spot On Your Watchlist?

Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?

Jun 30
Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?

Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Jun 12
Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

May 23
Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?

Mar 29
Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?

Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Mar 11
Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 28%?

Feb 21
Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 28%?

Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching

Dec 28
Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching

These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well

Dec 10
These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well

Is ICON Public Limited Company (NASDAQ:ICLR) Trading At A 26% Discount?

Nov 22
Is ICON Public Limited Company (NASDAQ:ICLR) Trading At A 26% Discount?

Icon selected by BARDA to conduct anthrax vaccine clinical trial

Oct 06

Is ICON Public Limited Company (NASDAQ:ICLR) Potentially Undervalued?

Sep 15
Is ICON Public Limited Company (NASDAQ:ICLR) Potentially Undervalued?

ICON (NASDAQ:ICLR) Seems To Use Debt Quite Sensibly

Aug 26
ICON (NASDAQ:ICLR) Seems To Use Debt Quite Sensibly

Baron Funds - ICON Plc: Positioned For An Extended Period Of Revenue And Earnings Growth

Aug 11

Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 41%?

Aug 01
Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 41%?

Analyse CEO-vergoeding

Hoe is Steve Cutler's beloning veranderd ten opzichte van ICON's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

US$748m

Jun 30 2024n/an/a

US$714m

Mar 31 2024n/an/a

US$683m

Dec 31 2023US$7mUS$1m

US$612m

Sep 30 2023n/an/a

US$513m

Jun 30 2023n/an/a

US$510m

Mar 31 2023n/an/a

US$510m

Dec 31 2022US$10mUS$1m

US$505m

Sep 30 2022n/an/a

US$464m

Jun 30 2022n/an/a

US$210m

Mar 31 2022n/an/a

US$168m

Dec 31 2021US$10mUS$1m

US$153m

Sep 30 2021n/an/a

US$178m

Jun 30 2021n/an/a

US$364m

Mar 31 2021n/an/a

US$338m

Dec 31 2020US$8mUS$1m

US$328m

Sep 30 2020n/an/a

US$322m

Jun 30 2020n/an/a

US$324m

Mar 31 2020n/an/a

US$368m

Dec 31 2019US$8mUS$1m

US$369m

Sep 30 2019n/an/a

US$362m

Jun 30 2019n/an/a

US$353m

Mar 31 2019n/an/a

US$333m

Dec 31 2018US$8mUS$1m

US$323m

Sep 30 2018n/an/a

US$306m

Jun 30 2018n/an/a

US$295m

Mar 31 2018n/an/a

US$288m

Dec 31 2017US$7mUS$1m

US$281m

Compensatie versus markt: De totale vergoeding ($USD 7.24M ) Steve } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.66M ).

Compensatie versus inkomsten: De vergoeding van Steve is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Steve Cutler (64 yo)

7.7yrs

Tenure

US$7,244,000

Compensatie

Dr. Steven A. Cutler, also known as Steve, Ph D., MBA, serves as Chairman of Association of Clinical Research Organizations since January 01, 2021. He has been the Chief Executive Officer of ICON Public Li...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Steven Cutler
CEO & Director7.7yrsUS$7.24m0.045%
$ 7.9m
John Climax
Founder & Independent Non-Executive Directorno dataUS$290.00k0.54%
$ 96.4m
Nigel Clerkin
Chief Financial Officerless than a yeargeen gegevensgeen gegevens
Jonathan Curtain
Senior Vice President of Corporate & Commercial Financeno datageen gegevensgeen gegevens
Thomas O'Leary
Chief Information Officerno datageen gegevensgeen gegevens
Diarmaid Cunningham
Chief Administrative Officer15yrsgeen gegevens0.0097%
$ 1.7m
Niamh Murphy
Director of Corporate Communicationsno datageen gegevensgeen gegevens
David Green
Vice President of Marketingno datageen gegevensgeen gegevens
Joe Cronin
Chief Human Resources Officer8.3yrsgeen gegevensgeen gegevens
Simon Holmes
President of Corporate Investments & Partnerships2yrsgeen gegevensgeen gegevens
Gary Curtis
Senior Vice President of Global Clinical Pharmacology15.6yrsgeen gegevensgeen gegevens
Peter Schueler
Senior Vice President of Drug Development Services - CNS17.8yrsgeen gegevensgeen gegevens

8.3yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van ICLR is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8.3 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Steven Cutler
CEO & Director9yrsUS$7.24m0.045%
$ 7.9m
John Climax
Founder & Independent Non-Executive Director14.8yrsUS$290.00k0.54%
$ 96.4m
Linda Grais
Independent Director3.3yrsUS$303.00k0.0054%
$ 949.9k
Eugene McCague
Independent Non-Executive Director7.1yrsUS$323.00k0.0026%
$ 454.6k
Ciaran Murray
Independent Non-Executive Chairman of the Board13.1yrsUS$656.00k0.023%
$ 4.1m
Ronan Murphy
Lead Independent Director8.1yrsUS$359.00k0.0026%
$ 454.6k
Anne Michelle Whitaker
Non-Executive Directorless than a yeargeen gegevensgeen gegevens
Julie O'Neill
Independent Non-Executive Director5.3yrsUS$315.00k0.0023%
$ 413.9k

7.6yrs

Gemiddelde duur

64.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van ICLR wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.6 jaar).